首页> 美国卫生研究院文献>other >Adherence to Levothyroxine Tablet in Patients with Hypothyroidism
【2h】

Adherence to Levothyroxine Tablet in Patients with Hypothyroidism

机译:甲状腺功能减退症患者对左甲状腺素片的依从性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionPatients with hypothyroidism are managed with life-long levothyroxine (LT4) therapy. However, as with other chronic illnesses, drug adherence (DA) is a prominent issue in these patients. The aim of this study is to identify the extent of DA to LT4 in hypothyroidism patients and study the clinical factors contributing to DA in these patients.MethodsThis cross-sectional study assessed patient adherence to LT4 therapy by Modified Morisky Adherence Scale (MMAS). Factors predicting the pattern of medication adherence were also assessed in all patients. Data were entered and analyzed using SPSS v. 22.0.ResultsOn MMAS, 79 (27.3%) participants indicated low adherence, 117 (40.48%) indicated medium adherence, and 93 (32.2%) participants indicated high adherence. Regular endocrinologist visits and knowledge about medication were highest in high adherent patients (p < 0.05). Need for assistance in taking medication, avoidance of medication with symptomatic relief and busy work schedule was highest in low adherent patients (p < 0.05).ConclusionPatients with hypothyroidism showed moderate adherence to their treatment.
机译:简介甲状腺功能减退的患者可以终生使用左甲状腺素(LT4)治疗。但是,与其他慢性病一样,药物依从性(DA)在这些患者中是一个突出的问题。这项研究的目的是确定甲状腺功能减退症患者中DA对LT4的程度,并研究这些患者中导致DA的临床因素。方法本横断面研究采用改良的Morisky坚持量表(MMAS)评估了患者对LT4治疗的依从性。还评估了所有患者的预测药物依从性的因素。使用SPSS v.22.0输入和分析数据。结果在MMAS上,有79位(27.3%)参与者表示依从性低,117位(40.48%)表示中等依从性,93名(32.2%)参与者表示高依从性。在高依从性患者中,定期的内分泌学家访视和药物知识最高(p <0.05)。依从性低的患者在服药,对症缓解和避免工作繁忙的情况下对药物的需求最高(p <0.05)。结论甲状腺功能低下的患者对治疗的依从性中等。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号